ArticleJournal of experimental & clinical cancer research : CR2017

Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells.

Yeonhwa Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.